Harel Insurance Investments & Financial Services’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-314
Closed – – 536
2024
Q3
$0 Hold
314
– – ﹤0.01% 587
2024
Q2
$0 Hold
314
– – ﹤0.01% 585
2024
Q1
$1K Hold
314
– – ﹤0.01% 534
2023
Q4
$1K Hold
314
– – ﹤0.01% 589
2023
Q3
$3K Hold
314
– – ﹤0.01% 634
2023
Q2
$3K Hold
314
– – ﹤0.01% 674
2023
Q1
$2K Hold
314
– – ﹤0.01% 691
2022
Q4
$1K Hold
314
– – ﹤0.01% 676
2022
Q3
$2K Hold
314
– – ﹤0.01% 689
2022
Q2
$18K Hold
314
– – ﹤0.01% 641
2022
Q1
$19K Sell
314
-5,229
-94% -$266K ﹤0.01% 638
2021
Q4
$382K Buy
+5,543
New +$427K 0.01% 288

Harel Insurance Investments & Financial Services's NTBL Position: Q4 2024 in Review

Harel Insurance Investments & Financial Services sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2024, closing a stake of 314 shares.

Harel Insurance Investments & Financial Services first reported a position in NTBL in Q4 2021 and held it in 12 quarters. The position peaked at $382K in Q4 2021. 0 funds tracked by Wall St. Rank hold NTBL as of Q4 2024.

  • Harel Insurance Investments & Financial Services reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2024 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 314 Notable Labs, Ltd. Ordinary Shares shares in Q4 2024.
  • Harel Insurance Investments & Financial Services first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2021 and held it in 12 quarters.
  • Harel Insurance Investments & Financial Services's Notable Labs, Ltd. Ordinary Shares position peaked at $382K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2024.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2024, filed 21 Jan 2025.